Breast Cancer Research

New research done in the field of breast cancer has yielded interesting results. It seems that the progression of breast cancer can be slowed down by the reintrodcution of a protein that is normally absent in breast cancer cells, Fibulin-2. The exact mechanism is not known but multiple theories exist. A common problem with breast cancer is resistance to tamoxifen. Tamoxifen is used in cancer cells that display the estrogen receptor (ER). Research is being done on other factors that could influence sensitivity to tamoxifen and the impications thereof. Research has also shown that by activating or inhibiting certain signal pathways, cells can model normal cells rather than dense cancerous cell growths. More research has shown that there is a possibility that cancer cell DNA can be made available to enzymatic digestion.

All of these advancements will surely contribute to future development and research of breast cancer treatments. The full article can be found at http://www.medicalnewstoday.com/medicalnews.php?newsid=69180